CURATE.AI COR-Tx platform as a digital therapy and digital diagnostic for cognitive function in patients with brain tumour postradiotherapy treatment: protocol for a prospective mixed-methods feasibility clinical trial.

ABSTRACT:

Introduction

Conventional interventional modalities for preserving or improving cognitive function in patients with brain tumour undergoing radiotherapy usually involve pharmacological and/or cognitive rehabilitation therapy administered at fixed doses or intensities, often resulting in suboptimal or no response, due to the dynamically evolving patient state over the course of disease. The personalisation of interventions may result in more effective results for this population. We have developed the CURATE.AI COR-Tx platform, which combines a previously validated, artificial intelligence-derived personalised dosing technology with digital cognitive training.

Methods and analysis

This is a prospective, single-centre, single-arm, mixed-methods feasibility clinical trial with

SUBMITTER: Remus A 

PROVIDER: S-EPMC10603439 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature